Bjorn Oskarsson, MD

home / authors / bjorn-oskarsson-md

Associate professor of neurology at Mayo Clinic in Florida and director of the ALS Center of Excellence.

Articles

Clinicians Express Growing Optimism in ALS Research and Treatment Advancements

Christina Fournier, MD;John Novak, MD, MS;Bjorn Oskarsson, MD;Isabella Ciccone, MPH

June 23rd 2025

Experts in ALS care and research shared their optimism about emerging treatments, aiming to deepen scientific understanding, and the potential role of advocacy in accelerating progress. [WATCH TIME: 4 minutes]

Reviving ALS Awareness Campaigns to Reaffirm Support for the Patient Community

Christina Fournier, MD;John Novak, MD, MS;Bjorn Oskarsson, MD;Isabella Ciccone, MPH

June 22nd 2025

Experts discussed the ongoing importance of awareness, funding, and early diagnosis in amyotrophic lateral sclerosis, welcoming the return of the well-known Ice Bucket Challenge. [WATCH TIME: 5 minutes]

Highlighting the Collaborative and Inclusive Spirit of the ALS Nexus Conference

Christina Fournier, MD;John Novak, MD, MS;Bjorn Oskarsson, MD;Isabella Ciccone, MPH

June 21st 2025

Clinicians reflected on the unique, patient-centered format of the ALS Nexus conference and its potential role in accelerating ALS research and promoting care collaboration. [WATCH TIME: 4 minutes]

Using a Multidisciplinary Approach to Enhance Holistic Care for Patients With ALS

Christina Fournier, MD;John Novak, MD, MS;Bjorn Oskarsson, MD;Isabella Ciccone, MPH

June 20th 2025

A panel of neuromuscular experts emphasized the importance of interdisciplinary care in helping improve quality of life and outcomes among patients living with ALS. [WATCH TIME: 4 minutes]

Updates in Gene Therapy, Biomarkers, and AI Advancements for ALS Care Management

Christina Fournier, MD;John Novak, MD, MS;Bjorn Oskarsson, MD;Isabella Ciccone, MPH

June 19th 2025

Experts discussed promising developments in ALS treatment, including gene-targeted therapies, emerging biomarkers, and AI-powered tools for diagnosis and patient support. [WATCH TIME: 5 minutes]